Founded in 1990, GATC Biotech is Europe's leading sequencing services provider with 10,000 customers from academia, healthcare and industry worldwide. The company has consistently contributed to the sequencing field with innovative products, use of latest technologies, scientific expertise and rigorous quality control.
The corporate business is divided into three product divisions - Sequencing Solutions, Customized Solutions and Diagnostic Solutions. As a renowned brand, GATC Biotech does not only master a broad range of technologies and downstream data analysis, it also processes millions of samples in a professional manner and ready for diagnostic purposes.
Currently, the entrepreneurial energy is focused on a completely new approach in the area of personalised medicine. The so-called liquid biopsy is a non-invasive blood test with enormous diagnostic and treatment potential for oncology.